ATE227996T1 - Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod - Google Patents

Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod

Info

Publication number
ATE227996T1
ATE227996T1 AT98938555T AT98938555T ATE227996T1 AT E227996 T1 ATE227996 T1 AT E227996T1 AT 98938555 T AT98938555 T AT 98938555T AT 98938555 T AT98938555 T AT 98938555T AT E227996 T1 ATE227996 T1 AT E227996T1
Authority
AT
Austria
Prior art keywords
composition
cell
regulating
dna
cell proliferation
Prior art date
Application number
AT98938555T
Other languages
English (en)
Inventor
Nigel C Phillips
Mario C Fillion
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Application granted granted Critical
Publication of ATE227996T1 publication Critical patent/ATE227996T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98938555T 1997-08-05 1998-08-05 Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod ATE227996T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5477797P 1997-08-05 1997-08-05
US7506798P 1998-02-18 1998-02-18
US7511198P 1998-02-18 1998-02-18
US8631798P 1998-05-21 1998-05-21
PCT/CA1998/000744 WO1999007383A1 (en) 1997-08-05 1998-08-05 Composition and method for regulating cell proliferation and cell death

Publications (1)

Publication Number Publication Date
ATE227996T1 true ATE227996T1 (de) 2002-12-15

Family

ID=27489673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98938555T ATE227996T1 (de) 1997-08-05 1998-08-05 Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod

Country Status (17)

Country Link
US (2) US6329347B1 (de)
EP (1) EP1003525B1 (de)
JP (2) JP4335435B2 (de)
KR (1) KR100533576B1 (de)
AT (1) ATE227996T1 (de)
AU (1) AU736450B2 (de)
BR (1) BR9815602A (de)
CA (1) CA2299548C (de)
DE (1) DE69809561T2 (de)
DK (1) DK1003525T3 (de)
ES (1) ES2187047T3 (de)
HU (1) HU227921B1 (de)
IL (3) IL134371A0 (de)
NO (1) NO322450B1 (de)
NZ (1) NZ502674A (de)
PT (1) PT1003525E (de)
WO (1) WO1999007383A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
DE69829316T2 (de) * 1998-02-18 2006-04-13 Bioniche Life Sciences Inc., Belleville Behandlung des harnblasenkrebses durch mycobacterium phlei zellwand
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
WO2000033875A1 (en) * 1998-12-04 2000-06-15 Bioniche Life Sciences Inc. Chemotherapeutic composition and method
ATE273027T1 (de) * 1998-12-04 2004-08-15 Bioniche Life Sciences Inc Zusammensetzung zur behandlung von entzündungen
JP2002541114A (ja) * 1999-04-01 2002-12-03 バイオニケ ライフ サイエンシーズ インコーポレイテッド 前立腺癌の細胞におけるアポプトーシス誘導のための組成物および方法
US6794368B1 (en) 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
US7314926B1 (en) 1999-04-08 2008-01-01 Antisoma Research Limited Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
AU7501700A (en) * 1999-09-29 2001-04-30 Bioniche Life Sciences Inc. Method to disrupt mitochondrial function
PT1238070E (pt) * 1999-12-13 2007-11-06 Bioniche Life Sciences Inc Oligonucleótidos sintéticos úteis sob o ponto de vista terapêutico
EP1250152B1 (de) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Hyaluronsäure enthaltende synergistische Zusammensetzung zur Krebsbehandlung
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US6673566B1 (en) 2002-01-10 2004-01-06 The United States Of America As Represented By The Secretary Of Agriculture Diagnosis of pathogen infections through analysis of nitrite production by antigen stimulated leukocytes
EP2043692B1 (de) * 2006-07-25 2016-05-18 Lipoxen Technologies Limited Polysaccharidderivate des erythropoietin
AU2011315093B2 (en) 2010-10-13 2013-10-17 Telesta Therapeutics Ip Inc. Bacterial ribonucleic acid cell wall compositions and methods of making and using them

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
FR2160326B1 (de) 1971-11-19 1975-02-07 Anvar
US4152423A (en) 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
CH602920A5 (de) 1973-02-23 1978-08-15 Wellcome Found
US3976544A (en) 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042A1 (fr) 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS54140710A (en) 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
DE3011461C2 (de) 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
US4520019A (en) 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4744984A (en) 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
AU691797B2 (en) 1993-01-29 1998-05-28 Vetrepharm, Inc. Immunotherapeutic composition
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法

Also Published As

Publication number Publication date
JP4335435B2 (ja) 2009-09-30
NO20000576D0 (no) 2000-02-04
JP2008208140A (ja) 2008-09-11
NO20000576L (no) 2000-04-04
AU736450B2 (en) 2001-07-26
IL180924A0 (en) 2007-07-04
NO322450B1 (no) 2006-10-09
HUP0003012A3 (en) 2004-03-29
IL134371A (en) 2007-07-24
EP1003525B1 (de) 2002-11-20
IL180924A (en) 2010-11-30
DK1003525T3 (da) 2003-03-24
WO1999007383A1 (en) 1999-02-18
DE69809561T2 (de) 2003-09-25
US6326357B1 (en) 2001-12-04
CA2299548C (en) 2009-12-29
HUP0003012A2 (hu) 2000-12-28
US6329347B1 (en) 2001-12-11
KR20010022643A (ko) 2001-03-26
IL134371A0 (en) 2001-04-30
EP1003525A1 (de) 2000-05-31
ES2187047T3 (es) 2003-05-16
DE69809561D1 (de) 2003-01-02
HU227921B1 (hu) 2012-06-28
WO1999007383B1 (en) 1999-03-25
CA2299548A1 (en) 1999-02-18
BR9815602A (pt) 2001-12-11
NZ502674A (en) 2002-06-28
AU8723698A (en) 1999-03-01
PT1003525E (pt) 2003-03-31
KR100533576B1 (ko) 2005-12-05
JP2001513504A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
IL180924A (en) Method for regulating cell proliferation and cell death
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
DE69737684D1 (de) Präzise wirksamkeitsbestimmungsmethode für wirkstoffe einschliesslich chemotherapeutika
AU9058091A (en) Preparation of nucleic acid samples
AU1926899A (en) Exploiting genomics in the search for new drugs
NL7610984A (nl) Werkwijze voor het bestuderen van enzymatische andere biochemische reacties.
DE69434342D1 (de) Verfahren zur selektiven Stimulierung der T-Zellproliferation.
DK0389063T3 (da) Fremgangsmåde til isolering af nukleinsyre
EP0599651A3 (de) Bioreaktor für die Perfusionskultur von Zellen.
DE69836491D1 (de) Fibrinmikrokugeln und deren verwendungen
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
IT8820920A0 (it) Dispositivo di fermentazione per la coltura aerobica di microorganismi.
DE3676148D1 (de) Antigerinnungsmittel, verfahren zu seiner herstellung und dieses mittel als wirkender grundstoff enthaltende antikoagulantia.
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
NL7808970A (nl) Werkwijze en inrichting voor het uitvoeren van electro- chemische reacties alsmede daarvoor geschikte bipolaire electroden.
FI885436A7 (fi) Fermenttori soluviljelmien viljelemiseksi
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
TR200001486T2 (tr) Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
FI801752A7 (fi) Menetelmä mikro-organismien aineenvaihdunta-aktiviteetin optimoimiseksi biologisen reaktiojärjestereaktiojärjestelmän substraatissa.
BR9305035A (pt) Agentes de curtimento e sua aplicaçáo
IT8721047A0 (it) Dispositivo per culture microbiologiche.
ATE302264T1 (de) Freigabe von intrazellulärem material
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003525

Country of ref document: EP